allfeeds.ai

 

The COVID-19 LST Report  

The COVID-19 LST Report

Author: COVID19LST

Language: en

Genres: Health & Fitness, Medicine

Contact email: Get it

Feed URL: Get it

iTunes ID: Get it

Trailer:


Get all podcast data

Listen Now...

Week of February 15th, 2021
Tuesday, 23 February, 2021

In today's episode we discuss: —Climate: Infectious Disease Society of America (IDSA) made 4 strong recommendations for preventing COVID-19 infection in health care personnel. A pulmonologist and interventional cardiologist from the Cleveland Clinic and Emory University critique recently published IDSA guidelines for preventing COVID-19 infection in healthcare workers. They argue the recommendation to use either respirators or surgical masks conflicts with Centers for Disease Control guidance to use respirators, and believe the guidelines are missing recommendations on proper gloving strategies, which are crucial to avoid self-contamination. The authors suggest the IDSA must clarify these points to alleviate confusion for healthcare workers who are inundated with recommendations from multiple organizations. —Transmission & Prevention: A retrospective observational study conducted by physicians at the Military Instruction Hospital during April 2020 found that among 1,739 crew members aboard a French aircraft carrier in April 2020, 64% tested positive for COVID-19 via real-time polymerase chain reaction (RT-PCR), with there being significant variations in symptomatic presentation and antibody development. This article suggests viral circulation in local outbreaks requires further testing and analysis. —Management: Remdesivir for adults with COVID-19 may decrease time on mechanical ventilation. A multi-specialty team from Minnesota and Oregon conducted a systematic review of 5 randomized-controlled trials evaluating remdesivir as a treatment for adults with COVID-19. They found that a 10-day course of remdesivir may reduce the proportion of patients receiving mechanical ventilation (RR: 0.71 [CI, 0.56 to 0.90]; 3 RCTs), but was associated with a statistically insignificant decrease in mortality (RR: 0.93 [95% CI, 0.82 to 1.06]; 4 RCTs) compared to control groups. Authors suggest that remdesivir use probably confers little to no mortality benefit, but may improve recovery by reducing time on mechanical ventilation. —Adjusting Practice During COVID-19: Methodological quality has been lower in some COVID-19 clinical research. As part of a systemic review of COVID-19 research quality, a team of molecular biologists, physicians, and statisticians from the University of Ottawa compared the quality of 686 research articles published during the COVID-19 pandemic to 593 historical controls matched for journal and study design published pre-pandemic. COVID-19 publications had a shorter time to acceptance (13.0 vs. 110 days, p<0.0001) and lower methodological quality scores compared to historical controls. Authors suggest the push for rapid research during the pandemic may result in lower quality research, and highlight the need for higher quality evidence. —R&D: Diagnosis & Treatments: SARS-CoV-2 lethal infected with K18-hACE2 transgenic mice may offer post-exposure protection. Researchers from the Israel Institute for Biological Research in Ness-Ziona, Israel analyzed the efficacy of monoclonal MD65 antibodies in K18-hACE2 transgenic mice with SARS-CoV-2 infection, finding a greater survival rate compared to mice without MD65 antibodies, in the setting of both prophylactic and post-exposure administration, as well as decreased viral load in lung tissue. 

 

We also recommend:


Beckers Healthcare -- Ambulatory Surgery Centers Podcast
Becker's Healthcare

ROCKET SCIENCE | Gesundheit und Leistung mit Doc Golo

The Grand Round Up
The Grand Round Up

Sistema Sensorial
jliacherry

Be Perfectly Healthy
User 540661506


/

FISIO TE RESPONDE
Gabriel Boaventura

Uso de animais em experimentos
Yasmim Albuquerque

Dr. Bones
NPO Luister / HUMAN / VPRO

The DIGA Podcast
DIGA

BondAir
Bond Vet

Age of Aging
Penn Memory Center